Giorgio Camilli is a skilled scientist with extensive experience in immunology and host-pathogen interactions. At King's College London, from January 2020 to February 2023, Giorgio focused on the immunological responses of epithelial and myeloid cells to fungal pathogens. Prior to this, Giorgio was a Research Associate at Institut Pasteur, exploring Innate Immune Memory from December 2015 to November 2019. Presently, since March 2023, Giorgio serves as a Senior Scientist at AstraZeneca, specializing in target identification and validation for immune-mediated diseases. Giorgio's academic background includes a PhD in Immunology/Cell and Developmental Biology and a Master's degree in Biological and Biomedical Sciences, both obtained from Sapienza Università di Roma. Additionally, Giorgio has contributed to research on the regulation of HLA-E molecules and A-to-I RNA Editing in acute myeloid leukemia, showcasing a diverse range of expertise in the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices